US Edition
Published • loading... • Updated
Prerna Launches CANTEL: India’s First MicroRNA Based Blood Test for Breast Cancer Screening
Summary by Social News XYZ
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Prerna Launches CANTEL: India’s First MicroRNA Based Blood Test for Breast Cancer Screening
Business Wire India PrecisionRNA Biotech Pvt. Ltd. (Prerna), a leading healthcare innovation company from Hyderabad, today announced the launch of Cantel™, India’s first microRNA-based blood test for breast cancer screening. This groundbreaking test is set to transform early detection by offering a simple, convenient, and highly accurate alternative to traditional methods, addressing the critical screening gap that has led to late-stage diagnosi…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
